Skip to main content
Tirzepatide (Mounjaro) is a medication currently under evaluation for weight loss potential, and although not yet FDA-approved for this purpose, it has shown significant weight reduction in clinical trials. In studies, participants experienced average weight loss of 15-20.9% after 72 weeks, outperforming other medications like semaglutide.
You can buy Tirzepatide after enrolling as a patient.
For Use By
Delivery Method

Can I Buy Tirzepatide?

Patients can buy Tirzepatide as part of a specialized treatment plan. After a phone call from a treatment specialist, you will be enrolled as a patient, and the pharmacy will ship the medication straight to your door.

Do we offer Tirzepatide as part of a treatment plan?
Weight loss
Suppress hunger
Heart health
Reduce risk of heart disease

How Does Tirzepatide Work?

Control Hunger and Appetite

Tirzepatide (Mounjaro) is FDA-approved for lowering blood sugar in people with type 2 diabetes by activating clocose-dependent insulinotropic polypeptide (GIP) and glucagon-like polypeptide (GLP-1) receptors. It increases insulin production and lowers the amount of blood sugar produced in the liver.

In clinical trials, weight loss was a significant side-effect. Tirzepatide is not FDA-approved for weight loss but is used to treat overweight and obesity in adults, along with diet and exercise. Phase 3 clinical trials are currently underway to evaluate Tirzepatide’s weight loss potential, and Eli Lilly has received FDA Fast-Track designation for mounjaro.

In the SURMOUNT-1 clinical trial, average weight loss after 72 weeks was 15% for the 5 mg dose, 19.5% for the 10 mg dose, and 20.9% for the 15 mg dose.

SURPASS-2 clinical trial, a 40 week noninferiority trial comparing Mounjaro vs. Ozempic (+ metformin), reductions in body weight were greater with tirzepatide than with semaglutide (least-squares mean estimated treatment difference, -1.9 kg, -3.6 kg, and -5.5 kg, respectively; P<0.001 for all comparisons). The mean change in weight was 8.2% at the 5 mg dose, 10% at the 10 mg dose, and 11.8% at the 15 mg dose, compared with Ozempic’s 6.2% at the 1 mg dose.

Benefits of Tirzepatide

Tirzepatide provides the following potential benefits:
  • Lowers A1C
  • Reduces the risk of chronic diseases associated with type 2 diabetes and obesity
  • Less joint damage
  • Decreased risk for cardiovascular disease
  • Improved mobility
  • Decreased blood pressure

Want us to contact you?

Submit your info and we will contact you

Drug Details


What is Tirzepatide used for?

The indications for Tirzepatide include:
  • Type 2 diabetes mellitus
  • Used off-label to treat overweight and obesity in adult patients


You should avoid Tirzepatide if you are/have:

People with the following conditions should not take Tirzepatide:
  • Medullary thyroid cancer (MTC)
  • Multiple endocrine neoplasia (MEN2)
  • Gastroparesis
  • Allergy to tirzepatide or any of the medication excipients
  • Pregnant and/or breastfeeding
  • Type 1 diabetes mellitus
  • Kidney disease
  • Pancreatic disease
  • History of diabetic retinopathy
Tirzepatide Side Effects

What are the side effects of Tirzepatide?

Side effects noted in clinical trials include:
Common Tirzepatide Side Effects
  • Nausea
  • Diarrhea
  • Decreased appetite
  • Vomiting
  • Constipation
  • Dyspepsia - stomach pain
  • Abdominal pain
Rare Tirzepatide Side Effects
  • Risk of thyroid C-cell tumors
  • Pancreatitis
  • Hypoglycemia if used concomitantly with insulin secretagogues or insulin
  • Hypersentivity reactions
  • Acute kidney injury
  • Severe gastrointestinal disease
  • Worsening diabetic retinopathy
  • Acute gallbladder disease

Tirzepatide Dosage Information

Tirzepatide Dosage & Frequency

Typical Tirzepatide Dosage & Frequency
  • Start at the 2.5 mg dose once weekly; after 4 weeks on the 2.5 mg dose, increase to the 5 mg dose once weekly.
  • Administer once weekly, any time of day, with or without meals.


  • What is Tirzepatide?
  • FDA Approves Mounjaro (Tirzepatide) for Diabetes Treatment
  • Every dose of Mounjaro is superior to Ozempic® (semaglutide) 1 mg in reducing A1C1
  • MOUNJARO- tirzepatide injection, solution
  • Lilly's SURMOUNT-1 results published in The New England Journal of Medicine
  • Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes

Related Articles

Some articles that might shed some light on this treatment plan
11 Reasons Behind Excessive Hunger

11 Reasons Behind Excessive Hunger

November 15, 2022
Nothing is worse when trying to manage your weight or improve your athletic performance than feeling constantly hungry. Hunger causes physical symptoms such as stomach cramping and growling, shaki...
Where Can I Get Semaglutide Online? 

Where Can I Get Semaglutide Online? 

June 12, 2022
Semaglutide is the “generic name” for Ozempic, Rybelsus, and Wegovy. Novo Nordisk manufactures all three brand-name medications. Ozempic and Rybelsus are FDA-approved to treat type-2 diabetes, and...
Liraglutide for Weight Loss: Is it Effective and Safe?

Liraglutide for Weight Loss: Is it Effective and Safe?

March 20, 2023
Liraglutide is a safe and effective medication for treating type 2 diabetes mellitus and obesity. According to the World Health Organization (WHO), obesity rates have tripled since 1975. In the U....